Published in J Card Fail on January 06, 2010
The association between COPD and heart failure risk: a review. Int J Chron Obstruct Pulmon Dis (2013) 1.06
Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure: the Worcester Heart Failure Study. Chest (2015) 0.92
Statins in heart failure: do we need another trial? Vasc Health Risk Manag (2013) 0.88
Update in diagnosis and therapy of coexistent chronic obstructive pulmonary disease and chronic heart failure. J Thorac Dis (2012) 0.80
The prevalence and prognosis of resistant hypertension in patients with heart failure. PLoS One (2014) 0.77
Serial pulmonary function tests to diagnose COPD in chronic heart failure. Transl Respir Med (2014) 0.75
Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device. J Card Fail (2014) 0.75
Impact of airflow limitation in chronic heart failure. Neth Heart J (2017) 0.75
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J (2012) 18.18
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J (2011) 10.52
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am (2002) 5.95
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 4.62
Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity. Heart (2012) 3.36
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis (2011) 2.90
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J (2016) 2.70
Prevalence of diastolic dysfunction as a possible cause of dyspnea in the elderly. Am J Med (2005) 2.67
[ESC/EAS Guidelines for the management of dyslipidaemias]. Rev Esp Cardiol (2011) 2.21
Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation (2003) 2.06
High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery. Anesthesiology (2012) 2.01
Large maternal weight loss from obesity surgery prevents transmission of obesity to children who were followed for 2 to 18 years. Pediatrics (2006) 2.00
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. Int J Cardiol (2013) 1.95
[Why all these guidelines?]. Lakartidningen (2014) 1.92
Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction. Heart (2011) 1.65
Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study. J Am Coll Cardiol (2008) 1.64
Perioperative complications in a consecutive series of 1000 duodenal switches. Surg Obes Relat Dis (2011) 1.55
Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials--common patterns in TRITON, RECORD, and PLATO? Thromb Haemost (2012) 1.54
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery (2004) 1.51
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis (2011) 1.51
Assessment of bleeding events in clinical trials--proposal of a new classification. Am J Cardiol (2006) 1.50
Evaluation of the ulnopalmar arterial arches with pulse oximetry and plethysmography: comparison with the Allen's test in 1010 patients. Am Heart J (2004) 1.47
Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia. Cardiology (2011) 1.46
Twenty years of biliopancreatic diversion: what is the goal of the surgery? Obes Surg (2004) 1.45
Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke. Stroke (2011) 1.44
Surgical technique for an 'almost' percutaneous triple pelvic osteotomy for femoral head coverage in children 6-14 years of age. J Pediatr Orthop B (2004) 1.43
2016 European Guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed) (2016) 1.42
Maximizing scientific knowledge from randomized clinical trials. Am Heart J (2010) 1.42
Incidence and causes of new-onset dyspnea in 3,719 patients treated with clopidogrel and aspirin combination after coronary stenting. Thromb Haemost (2008) 1.40
New oral anticoagulants--a review. Tidsskr Nor Laegeforen (2013) 1.39
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace (2016) 1.39
[Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases]. Ugeskr Laeger (2004) 1.38
[Medical and ventilatory treatment of acute heart failure]. Tidsskr Nor Laegeforen (2006) 1.38
Should oxygen be given in myocardial infarction? BMJ (2010) 1.38
Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. Atherosclerosis (2008) 1.38
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J (2011) 1.34
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis (2007) 1.33
Matrix metalloproteinases in atherothrombosis. Prog Cardiovasc Dis (2010) 1.26
Androgenic anabolic steroid abuse and the cardiovascular system. Handb Exp Pharmacol (2010) 1.21
Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction. Am J Cardiol (2010) 1.20
Interrelation between the extent of atherosclerosis in the thoracic aorta, carotid intima-media thickness and the extent of coronary artery disease. Atherosclerosis (2004) 1.16
Frequency and significance of troponin T elevation in acute ischemic stroke. Am J Cardiol (2006) 1.13
Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke. Am J Cardiol (2009) 1.12
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul Fibrinolysis (2003) 1.12
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. Thromb Res (2006) 1.12
Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study. Ann Rheum Dis (2011) 1.11
Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension (2009) 1.10
Fluctuating inflammatory markers in patients with stable ischemic heart disease. Arch Intern Med (2005) 1.07
Duodenal switch: long-term results. Obes Surg (2007) 1.07
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus. Cardiovasc Diabetol (2010) 1.07
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? J Card Fail (2004) 1.05
Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study. Circulation (2004) 1.05
Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects. BMC Med Genomics (2010) 1.04
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J (2013) 1.03
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure. Circ Heart Fail (2013) 1.02
[Clinical and genetic aspects of congenital insensitivity to pain with anhidrosis]. Harefuah (2005) 1.01
Mechanism of troponin elevations in patients with acute ischemic stroke. Am J Cardiol (2007) 1.01
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation (2013) 0.99
Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. Am J Hypertens (2012) 0.97
Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF. Eur J Heart Fail (2012) 0.95
[ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)]. G Ital Cardiol (Rome) (2012) 0.95
Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease. Atherosclerosis (2007) 0.94
The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. J Am Coll Cardiol (2007) 0.94
An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area. Am Heart J (2002) 0.93
Long-Term Metabolic Outcomes 5 to 20 Years After Biliopancreatic Diversion. Obes Surg (2015) 0.92
New-onset atrial fibrillation in bacteremia is not associated with C-reactive protein, but is an indicator of increased mortality during hospitalization. Cardiology (2008) 0.91
Duodenal switch improved standard biliopancreatic diversion: a retrospective study. Surg Obes Relat Dis (2008) 0.91
Non-invasive assessment of endothelial function - relation between vasodilatory responses in skin microcirculation and brachial artery. Clin Physiol Funct Imaging (2004) 0.91
Hard tissue remodeling using biofabricated coralline biomaterials. J Biochem Biophys Methods (2002) 0.90
Does bone change after biliopancreatic diversion? J Gastrointest Surg (2002) 0.90
Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study. BMJ (2003) 0.90
Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke. PLoS One (2011) 0.89
Acute responses to phytoestrogens in small arteries from men with coronary heart disease. Am J Physiol Heart Circ Physiol (2005) 0.89
'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis. Ann Rheum Dis (2010) 0.89
Morphological changes rather than flow-mediated dilatation in the brachial artery are better indicators of the extent and severity of coronary artery disease. J Hypertens (2005) 0.89
The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study. Arthritis Res Ther (2008) 0.88
Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classifications. Eur Heart J (2009) 0.87
Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction. Am J Cardiol (2009) 0.87
Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges. Int J Cardiol (2013) 0.87